Adverum Biotechnologies Inc (NASDAQ:ADVM)

1.08
Delayed Data
As of Jun 24
 0.00 / 0.00%
Today’s Change
0.80
Today|||52-Week Range
3.86
-38.64%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 3
2018
Quarter 4
2018
Quarter 1
2019
Quarter 2
2019
AssetsCash159.7M154.9M144.1M97.8M
 
 
 
 
 
Short Term Investment Cash4.2M-4.7M-10.8M-46.3M
 
 
 
 
 
Cash & Short Term Investments217.9M205.1M189.5M177.6M
 
 
 
 
 
 
ReceivablesReceivables0.000.000.000.00--
 
InventoriesInventories0.000.000.000.00--
 
Current AssetsOther Current Assets4.3M3.7M3.6M2.9M
 
 
 
 
 
Current Assets222.2M208.8M193.1M180.6M
 
 
 
 
 
 
Total AssetsProperty, Plant and Equipment - Gross2.6M10.0M--35.4M
 
 
 
 
Depreciation---6.4M---7.3M
 
 
 
Other Assets140.0K156.0K174.0K174.0K
 
 
 
 
 
Total Assets225.9M213.5M221.0M209.9M
 
 
 
 
 
 
LiabilitiesAccounts Payable1.7M1.7M1.8M740.0K
 
 
 
 
 
Short Term Debt0.000.003.8M3.9M
 
 
 
Accrued Expenses4.8M4.4M3.3M3.3M
 
 
 
 
 
Other Current Liabilities5.5M6.1M3.7M3.8M
 
 
 
 
 
Other Liabilities10.1M10.7M10.6M10.1M
 
 
 
 
 
 
Total LiabilitiesLong Term Debt--0.0022.1M21.8M
 
 
 
Other Liabilities289.0K1.6M216.0K191.0K
 
 
 
 
 
Total Liabilities10.4M12.3M32.9M32.1M
 
 
 
 
 
 
EquityMinority Interest0.000.000.000.00--
Preferred Stock0.000.000.000.00--
Common Equity215.6M201.2M188.1M177.7M
 
 
 
 
 
Total Shareholder Equity215.6M201.2M188.1M177.7M
 
 
 
 
 
 
Share InformationCommon Shares Outstanding62.8M63.0M63.3M64.4M
 
 
 
 
 
 
Addtl. Info.No data currently available for this section.